TrialJournal of diabetes research2017

Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes.

Yingying Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.